🔎 Trials Near Me

Akèy › Kansè kanal bil (Kolangyokasinòm) › Massachusetts › Boston

Etid klinik pou Kansè kanal bil (Kolangyokasinòm) nan Boston, MA

8 etid pou Kansè kanal bil (Kolangyokasinòm) ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of PHST001 in Advanced Solid Tumors

Ap rekriteFaz 1
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06840886

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06302621

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Ap rekriteFaz 1
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study of MGC028 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Mass General Brigham, Boston
  • Dana Farber/Harvard Cancer Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT06723236

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05655949

Etid Kansè kanal bil (Kolangyokasinòm) nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.